Browse Subject Areas

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

PG1058 Is a Novel Multidomain Protein Component of the Bacterial Type IX Secretion System

  • Jacqueline E. Heath ,

    Contributed equally to this work with: Jacqueline E. Heath, Christine A. Seers

    Affiliation Oral Health Cooperative Research Centre, Melbourne Dental School, Bio21 Institute, The University of Melbourne, Melbourne, Australia

  • Christine A. Seers ,

    Contributed equally to this work with: Jacqueline E. Heath, Christine A. Seers

    Affiliation Oral Health Cooperative Research Centre, Melbourne Dental School, Bio21 Institute, The University of Melbourne, Melbourne, Australia

  • Paul D. Veith,

    Affiliation Oral Health Cooperative Research Centre, Melbourne Dental School, Bio21 Institute, The University of Melbourne, Melbourne, Australia

  • Catherine A. Butler,

    Affiliation Oral Health Cooperative Research Centre, Melbourne Dental School, Bio21 Institute, The University of Melbourne, Melbourne, Australia

  • Nor A. Nor Muhammad,

    Current address: Institute of Systems Biology (INBIOSIS), Universiti Kebangsaan Malaysia, Selangor, Malaysia

    Affiliation Oral Health Cooperative Research Centre, Melbourne Dental School, Bio21 Institute, The University of Melbourne, Melbourne, Australia

  • Yu-Yen Chen,

    Affiliation Oral Health Cooperative Research Centre, Melbourne Dental School, Bio21 Institute, The University of Melbourne, Melbourne, Australia

  • Nada Slakeski,

    Affiliation Oral Health Cooperative Research Centre, Melbourne Dental School, Bio21 Institute, The University of Melbourne, Melbourne, Australia

  • Benjamin Peng,

    Affiliation Oral Health Cooperative Research Centre, Melbourne Dental School, Bio21 Institute, The University of Melbourne, Melbourne, Australia

  • Lianyi Zhang,

    Affiliation Oral Health Cooperative Research Centre, Melbourne Dental School, Bio21 Institute, The University of Melbourne, Melbourne, Australia

  • Stuart G. Dashper,

    Affiliation Oral Health Cooperative Research Centre, Melbourne Dental School, Bio21 Institute, The University of Melbourne, Melbourne, Australia

  • Keith J. Cross,

    Affiliation Oral Health Cooperative Research Centre, Melbourne Dental School, Bio21 Institute, The University of Melbourne, Melbourne, Australia

  • Steven M. Cleal,

    Affiliation Oral Health Cooperative Research Centre, Melbourne Dental School, Bio21 Institute, The University of Melbourne, Melbourne, Australia

  • Caroline Moore,

    Affiliation Oral Health Cooperative Research Centre, Melbourne Dental School, Bio21 Institute, The University of Melbourne, Melbourne, Australia

  • Eric C. Reynolds

    Affiliation Oral Health Cooperative Research Centre, Melbourne Dental School, Bio21 Institute, The University of Melbourne, Melbourne, Australia


Porphyromonas gingivalis utilises the Bacteroidetes-specific type IX secretion system (T9SS) to export proteins across the outer membrane (OM), including virulence factors such as the gingipains. The secreted proteins have a conserved carboxy-terminal domain essential for type IX secretion that is cleaved upon export. In P. gingivalis the T9SS substrates undergo glycosylation with anionic lipopolysaccharide (A-LPS) and are attached to the OM. In this study, comparative analyses of 24 Bacteroidetes genomes identified ten putative novel components of the T9SS in P. gingivalis, one of which was PG1058. Computer modelling of the PG1058 structure predicted a novel N- to C-terminal architecture comprising a tetratricopeptide repeat (TPR) domain, a β-propeller domain, a carboxypeptidase regulatory domain-like fold (CRD) and an OmpA_C-like putative peptidoglycan binding domain. Inactivation of pg1058 in P. gingivalis resulted in loss of both colonial pigmentation and surface-associated proteolytic activity; a phenotype common to T9SS mutants. Immunoblot and LC-MS/MS analyses of subcellular fractions revealed T9SS substrates accumulated within the pg1058 mutant periplasm whilst whole-cell ELISA showed the Kgp gingipain was absent from the cell surface, confirming perturbed T9SS function. Immunoblot, TEM and whole-cell ELISA analyses indicated A-LPS was produced and present on the pg1058 mutant cell surface although it was not linked to T9SS substrate proteins. This indicated that PG1058 is crucial for export of T9SS substrates but not for the translocation of A-LPS. PG1058 is a predicted lipoprotein and was localised to the periplasmic side of the OM using whole-cell ELISA, immunoblot and LC-MS/MS analyses of subcellular fractions. The structural prediction and localisation of PG1058 suggests that it may have a role as an essential scaffold linking the periplasmic and OM components of the T9SS.


Chronic periodontitis is an inflammatory disease characterised by accretion of a polymicrobial biofilm (subgingival plaque) on the tooth, destruction of the supporting tissues of the teeth and ultimately tooth loss [1]. Periodontitis has been linked with systemic diseases including cardiovascular disease, rheumatoid arthritis, diabetes, preterm birth and low birth weight [2, 3]. The presence of Porphyromonas gingivalis, Tannerella forsythia, and Treponema denticola in the subgingival plaque is strongly associated with the clinical indicators of disease [4, 5]. In particular, subgingival plaque composed of greater than 10–15% P. gingivalis cells is a predictor of imminent disease progression [6]. In addition, this Gram-negative, black-pigmented, anaerobic bacterium has been described as a keystone pathogen of the disease, which through dysregulation of the local immune response disrupts homeostasis causing dysbiosis and disease progression [79].

P. gingivalis produces a variety of surface-associated virulence factors implicated in pathogenesis, including lipopolysaccharide (LPS), fimbriae, capsular polysaccharide, haemagglutinin (HagA) and the gingipains [10]. The gingipains are Lys-specific (Kgp) and Arg-specific (RgpA and RgpB) cysteine proteinases, considered to be the bacterium’s major virulence factors responsible for ~85% of its proteolytic activity, and are hence the most studied [8, 1114].

The gingipains belong to a group of 34 surface-associated proteins in P. gingivalis with a conserved carboxy-terminal domain (CTD) [15]. The CTD has been suggested to contain a C-terminal secretion signal as when removed from the proteins RgpB and haemin binding protein HBP35 they were not secreted from the periplasm [1517]. This was corroborated by the secretion and modification of green fluorescent protein when it was fused with the CTD sequence from either RgpB, CPG70, peptidylarginine deiminase (PAD) or P27 [17, 18].

The CTD-family proteins are also known to be extensively glycosylated [1921]. This modification is recognised by the monoclonal antibody MAb 1B5 [19]. MAb 1B5 recognises a phosphorylated branched mannan epitope (Manα1–2 Manα1-phosphate) found in anionic polysaccharide (APS), the polysaccharide repeating unit of the anionic lipopolysaccharide (A-LPS) produced by P. gingivalis [22]. The A-LPS modification is covalently linked to the mature C-terminus of the CTD-family proteins and has been proposed to be responsible for tethering them to the cell surface [23, 24].

Several P. gingivalis proteins have been shown to have a role in the secretion and modification of CTD-family proteins. Mutations in the genes coding PorT [18], Sov [25] and LptO (PorV/PG27) [26] resulted in a non-pigmented phenotype and reduced or no gingipain activity, indicative of defective secretion. CTD-family proteins and homologues of porT are present in some members of the Bacteroidetes phylum such as Cytophaga hutchinsonii, but absent from Bacteroides thetaiotaomicron [27]. Comparative genome analysis of genes present in P. gingivalis and C. hutchinsonii but absent in B. thetaiotaomicron was conducted to identify those coding for proteins with possible involvement in CTD-family protein secretion. Fifty-five genes were identified of which gene inactivation and phenotype analyses revealed porK, porL, porM, porN, porP, porQ, porU (pg0026), porW, porX and porY to code components of the secretion system, with accumulation of CTD-family proteins in the periplasm and decreased gingipain activity associated with cells and culture supernatants of the mutants [27]. The PorSS (Por secretion system) identified by Sato et al. [27], now commonly referred to as the type IX secretion system (T9SS), is responsible for the OM secretion and surface-association of CTD-family proteins in Bacteroidetes spp., utilising the Sec pathway for inner membrane (IM) transit [17, 2729].

Although several proteins have been identified as components of the T9SS, knowledge of their actual function is limited. PorX and PorY have been suggested to be a putative response regulator and a putative histidine kinase respectively, of a two-component signal transduction system and were shown to regulate porT, sov, porK, porL, porM, porN and porP expression in P. gingivalis [27, 30]. Recent work has shown a direct interaction between recombinant PorX and PorY proteins, with rPorY exhibiting histidine kinase activity [31]. Furthermore, PorK and PorN have recently been shown to interact to form large ring-shaped complexes of 50 nm diameter. These rings appeared to be located on the periplasmic face of the OM and were suggested to be part of the translocation apparatus [32].

P. gingivalis W50 and ATCC 33277 mutants lacking LptO accumulate A-LPS and unmodified substrates in the periplasm [33]. Mass spectrometry showed P. gingivalis W50 possesses tetra- and penta-acylated forms of mono-phosphorylated lipid A whilst the lptO mutant exhibited only penta-acylated mono-phosphorylated lipid A consistent with its accumulation in the periplasm prior to surface deacylation [33]. A P. gingivalis ATCC 33277 porT mutant showed a similar phenotype to the lptO mutant in regards to the accumulation of substrates in the periplasm, except that the porT mutant exhibited a lipid A profile similar to that of wild-type [33]. This indicated that LptO is required for the normal O-deacylation of mono-phosphorylated lipid A in P. gingivalis, suggesting that LptO is essential for the normal translocation of A-LPS and the coordinated secretion/attachment of T9SS substrates [33].

PorU (PG0026), a surface-associated CTD-family protein which lacks glycosylation, was determined to be a signal peptidase responsible for the cleavage of the CTD from the other T9SS substrates in P. gingivalis [34]. Although T9SS substrates largely accumulated in the periplasm of a pg0026 (porU) mutant, of those that were surface-exposed the CTD was not cleaved from the precursor proteins and the proteins were not modified with A-LPS [34].

Recently analysis of a wbaP mutant that is defective in A-LPS synthesis showed that T9SS substrates were secreted into the culture fluid with their CTDs cleaved. In place of the CTD sequences were a variety of amino acids and peptides from the growth medium [23]. This suggested that CTD-cleavage and modification of the T9SS substrates by PorU occurs through a sortase-like mechanism [23]. It was also revealed that LptO associates with PorU, suggesting that the integral OMP LptO is involved in tethering PorU to the cell surface [35, 36]. Furthermore, the close association of these two proteins could provide the link between A-LPS translocation and presentation to the CTD sortase to anchor the T9SS substrate proteins at the cell surface.

Although several proteins have been established as essential components of the T9SS with some localised within the cell, the precise functions of most of the components remain unknown. To explore whether all components of the T9SS in P. gingivalis have been identified we extended the bioinformatic approach of Sato et al. [27] and report the identification of several novel putative T9SS components and demonstrate experimentally that one of these is important for the function of the T9SS in P. gingivalis.


Bioinformatic prediction of T9SS components

Identification of T9SS components was previously conducted by Sato et al. [27], using a genome comparison approach of P. gingivalis and C. hutchinsonii, which possess CTD-family proteins, and B. thetaiotaomicron which does not [27]. To identify additional T9SS components this bioinformatic approach was extended whereby the genomes of twenty-four Bacteroidetes spp. were examined using BLASTp, for the ability to code for proteins which are also coded by the P. gingivalis W83 genome. The species were separated into those coding for CTD-family proteins (CTD-positive) and those which did not (CTD-negative). Thirty-seven P. gingivalis W83 proteins with an average BLASTp score at least two times greater in the CTD-positive species than in the CTD-negative species were shortlisted. The list was further refined to include twenty-nine candidates based on BLAST verification of the species distribution (Table 1).

Table 1. T9SS components predicted using the differential genomics approach.

This method successfully predicted twelve known Por proteins and Sov, previously considered to be T9SS components. Furthermore, PG0162 and PG0534 predicted by this analysis were previously implicated in secretion whereby mutants exhibited reduced gingipain production when the genes coding for these proteins were inactivated [31, 37, 38]. Prediction of PG1604 herein supports the previous proposition that PG1604 could be a T9SS component due to sequence similarity with the CTD of PorU and the lack of glycosyl modification [21]. PG0133, PG0236 and PG0945 were also previously predicted to be components of the T9SS [27] however no supporting experimental evidence has yet been reported for these proteins. Ten newly identified T9SS candidates remained, one is potentially involved in polysaccharide biosynthesis (PG0264), one in lipid synthesis (PG2071) and one is a putative TonB-linked receptor (PG0441). The remaining seven proteins have no potential function assigned at this stage. PG1058 was the first of these novel proteins selected for further investigation.

The predicted structure of PG1058

Bioinformatic analyses of the PG1058 sequence using Pfam and the conserved domain database indicated that PG1058 consists of four domains. Beginning from the N-terminus, the first domain contains tetratricopeptide repeats (TPR) (residues 71–131; pfam13432) [40, 41] and the second domain contains a WD40 repeat (residues 226-262, pfam07676) [42, 43]. However prediction with the InterPro database suggests a longer domain encompassing residues 167–433 with five repeats, potentially forming a β–propeller structure. The putative β–propeller domain is followed by a domain with a predicted carboxypeptidase regulatory domain-like fold (CRD; residues 443-525, pfam13620). The C-terminal domain is an OmpA_C-like domain (residues 536-666; CD07185), responsible for the annotation of PG1058 as an OmpA-family protein [4446]. Thus PG1058 is predicted to be a modular protein. Structure predictions using Phyre2 supported the Pfam predictions as indicated by the models generated (Fig 1, S1 Fig). PG1058 is predicted to be a lipoprotein due to the presence of an N-terminal type II signal peptide. We know of no characterised protein that has a domain architecture like that predicted for PG1058.

Fig 1. Phyre2 modelling of PG1058 predicted structural domains.

Structures are coloured from blue at the N-terminus to red at the C-terminus. A. A TPR domain with three anti-parallel α-helix repeats (α-helix repeats numbered 1–3) and one capping helix (denoted by C) [47]. PG1058 Lys25-Arg153 modelled at 99.9% confidence against c412wA, the myosin chaperone UNC-45 from Caenorhabditis elegans in complex with a Hsp70 peptide [48]. B. A five bladed β–propeller domain (blades numbered 1–5). PG1058 Asp167-Ala438 modelled at 99.9% confidence against c2w8bB, E. coli TolB (a six bladed propeller protein) in complex with Pal [49]. C. The CRD. PG1058 Ile443-Arg528 modelled at 99.5% confidence against cmn8A, Drosophila melanogaster carboxypeptidase d isoform 1b2 short [50]. D. An OmpA_C-like domain. PG1058 Asn536-Val666 modelled at 100.0% confidence against c1r1m1, the OmpA-like domain from RmpM of N. meningitidis [45] with three α-helices (α-helices numbered α1-α3) and an additional α-helix (αn) which has seven additional residues relative to RmpM which are not represented in this model.

An extensive bioinformatic analysis established that there were 424 proteins within the Bacteroidetes phylum with domain order similarity to PG1058, represented by 174 species from 70 genera across the 4 classes. Interestingly, while many species had one PG1058 homologue, some had multiple PG1058 homologues, ranging from 2 to 13 per species. Furthermore, some homologues had N-terminal and C-terminal extensions relative to PG1058. Multiple sequence alignment using one homologue from each genus (the highest scored BLASTp match to PG1058) when represented as a sequence logo shows highly conserved residues within each domain, especially in the β-propeller and OmpA_C-like domains (Fig 2). Alignment of the PG1058 homologues containing regions of additional residues relative to PG1058 showed the same regions of conservation, with the main differences being the N-terminal and C-terminal extensions, a possible domain (or additional blade) between repeat 1 and 2 of the β–propeller, and a longer CRD region due to insertions (data not shown).

Fig 2. PG1058 sequence conservation.

A representative sequence from each of the 70 genera with PG1058 homologues were aligned using CLUSTAL W [51] and a sequence logo was generated using WebLogo 3 [52, 53]. The approximate boundaries of the CRD and OmpA_C-like domains are indicated by arrows. Low homology regions are primarily due to insertions in some sequences, although overall identity in the CRD is lower than seen in the other domains. The three TPR repeats are boxed and the five β–propeller blades are in alternating gray and yellow boxes. The putative peptidoglycan binding motif is boxed in green.

Co-transcription of pg1056, pg1057 and pg1058

Scrutiny of the pg1058 locus indicated that it may be the third gene in a three gene operon including pg1056 and pg1057. RT-PCR analysis of P. gingivalis W50 transcripts confirmed that pg1058 is indeed part of an operon (S2A Fig). A pg1058 mutant was generated by insertional inactivation with ermF in the P. gingivalis W50 strain. The mutant was complemented in trans by chromosomal integration at the mfa1 locus, of a DNA fragment which contained pg1058 and cepA for recombinant selection. The recombinant was designated pg1058+. Non-endpoint RT-PCR analysis of the W50, pg1058 and pg1058+ strains indicated that transcription of pg1056 and pg1057 was not detrimentally affected in the pg1058 mutant and pg1058+ complement strains (S2B Fig). Thus a polar effect on those genes would be unlikely to account for any mutant phenotype observed.

The pg1058 mutant has an altered pigmentation, haemagglutination and proteolytic phenotype

P. gingivalis colonies grown on blood agar appear black due to the accumulation of haemoglobin-derived μ-oxo bishaem on the cell surface, in a process dependent on the proteolytic degradation of haemoglobin by T9SS substrates, the gingipains [5456]. As such, pigmentation is therefore also dependent on a functioning T9SS to present the gingipains on the cell surface. The pg1058 mutant exhibited altered colonial pigmentation on blood agar, which was reverted in the complement strain (Fig 3A). The ability of P. gingivalis to haemagglutinate erythrocytes is also linked to appropriate secretion and surface-association of gingipains and the haemagglutinin HagA. The pg1058 mutant showed a clear reduction in haemagglutination ability relative to W50 (Fig 3B). Proteinase activity assays indicated that the pg1058 mutant had significantly reduced cell-associated Arg- and Lys-specific proteolytic activities (Fig 3C). P. gingivalis W50 has an electron dense surface layer (EDSL) of ~20 nm thickness coating the surface of the cell that is visible in cryo-EM micrographs [33]. This coating has been shown to contain gingipains and other T9SS substrate proteins [23]. The pg1058 mutant lacked a visible EDSL in cryo-EM (Fig 3D) suggesting the absence of gingipains and other T9SS substrates on the cell surface.

Fig 3. Phenotypic characterisation of the pg1058 mutant compared to P. gingivalis W50.

A. Unlike P. gingivalis W50, the pg1058 mutant (pg1058) does not produce black pigment when grown on blood agar. The phenotype is restored following pg1058 complementation (pg1058+). B. The pg1058 mutant showed substantially reduced haemagglutination activity relative to P. gingivalis W50. Bacteria were 2-fold serially diluted from 20 to 211 in PBS and photographed after incubation with sheep erythrocytes at RT for 3 h. C. Arg-specific (indicative of the presence of RgpA and RgpB proteinases) and Lys-specific (indicative of the presence of Kgp proteinase) proteinase activity of W50 (wild-type), pg1058 mutant and pg1058+ complement strains in whole-cells and culture supernatants. Units per 2.5 x 1011 cells equates to amount of substrate hydrolysed in μmol/min/2.5 x 1011 cells whilst Units per 100 mL equates to amount of substrate hydrolysed in μmol/min/supernatant derived from 100 mL of culture containing 2.5 x 1011 cells. Inactivation of pg1058 abolished the Arg- and Lys-specific proteolytic activity of the cells, which was restored after pg1058 complementation. D. Absence of EDSL on the P. gingivalis pg1058 mutant. Cryo-EM micrographs representative of the P. gingivalis W50 and pg1058 mutant. Outer membrane (OM), inner membrane (IM), peptidoglycan (PGN) and electron dense surface layer (EDSL) are indicated. Scale bar is 200 nm.

Aberrant localisation of T9SS substrates in the pg1058 mutant

P. gingivalis W50 and pg1058 mutant periplasmic fractions were subjected to SDS-PAGE and Coomassie staining which revealed different protein profiles (Fig 4A). LC-MS/MS analysis of peptides extracted from the gel identified 255 proteins overall including 24 T9SS substrates and 20 proteins that have been previously localised to the periplasm. An accumulation of T9SS substrates in the periplasm of the pg1058 mutant was established by comparison of the total Mascot scores of the substrates, with several substrates detected only in the mutant (Fig 4A). Using this technique, PorU, both a substrate and component of the T9SS, was not detected in the W50 periplasm however was readily detected in the periplasm of the pg1058 mutant. This could be explained by accumulation of PorU in the periplasm of the mutant, suggesting that its secretion across the OM was hindered.

Fig 4. Aberrant localisation of T9SS substrates in the pg1058 mutant.

P. gingivalis W50 and pg1058 mutant periplasm (A) or total membrane (B) fractions were separated via SDS-PAGE and stained with SimplyBlue™ SafeStain. Each lane was divided into segments and analysed by LC-MS/MS. When the same protein was identified from multiple gel segments the Mascot scores were summed. The total Mascot score for the substrates identified from W50 (black bars) and the pg1058 mutant (white bars) were plotted on a logarithmic axis (left Y-axis). The total Mascot score for the combined substrates and the total Mascot scores for the combined periplasmic or membrane proteins were plotted on a linear axis (right Y-axis). Proteins are indicated by the Locus Tag in the P. gingivalis W83 strain unless previously designated with a protein ID.

Given the identification of T9SS substrates accumulating in the periplasm of the pg1058 mutant it follows that the OM proteome of the pg1058 mutant may have altered. Total membrane fractions from W50 and the pg1058 mutant were therefore also subjected to proteome analysis similar to that performed on the periplasm fractions. In the membranes 278 proteins were identified overall including 11 T9SS substrates. A lower abundance of T9SS substrates in the membrane fraction of the pg1058 mutant was indicated by a lower total Mascot score for the substrates when compared to W50 (Fig 4B). The accumulation of T9SS substrates in the periplasm with a coincident reduction in the membrane of the pg1058 mutant in comparison to W50 was consistently observed across multiple biological replicates indicating a perturbation of the T9SS (data not shown).

To further interrogate the localisation and processing of substrates in the pg1058 mutant, W50, pg1058 mutant and pg1058+ complement strain cultures were separated into subcellular fractions and subjected to immunoblot analyses. Use of antiserum against the Kgp catalytic domain (anti-rKgpcat) revealed Kgp as a distinct band of ~51 kDa, corresponding to the mature catalytic domain (Kgpcat), in all W50 and pg1058+ complement fractions except for the periplasm fractions where it was absent. Kgpcat was mainly cell-associated in the pg1058 mutant and detected as a high MW band of ~180 kDa corresponding to the Kgp precursor polypeptide (186 kDa) (Fig 5A).

Fig 5. Aberrant localisation of proteinases in subcellular fractions of the pg1058 mutant.

P. gingivalis W50, pg1058 mutant and pg1058+ complement strain cultures were fractionated, separated via SDS-PAGE and immunoblotted on nitrocellulose membranes. The immunoblots have material derived from whole-cells (WC; 2 x 108 cells), total membrane (3 x 108 cells) and soluble (1 x 108 cells) fractions; WC, periplasm and osmotically-shocked cell (OSC) fractions (5 x 108 cells each); WC (2 x 108 cells), culture fluid (CF; from culture containing 2 x 109 cells) and vesicle-free cleared culture fluid (CCF; from culture containing 2 x 109 cells). Immunoblots were probed with either anti-rKgpcat (A, 1/200,000 dilution), pre-adsorbed anti-rRgpAcat (B, 1/10,000 dilution), anti-rKgpA1 (C, 1/10,000 dilution) or anti-rRgpB-CTD422 (D, 1/200,000 dilution) followed by goat anti-rabbit (A) or horse anti-mouse (B, C and D) IgG-conjugated HRP secondary antibodies (1/3,000 dilution).

Similar to the Kgpcat result, immunoblot with antiserum against the RgpA catalytic domain (anti-rRgpAcat) detected a high MW band (~180 kDa) in the pg1058 mutant whole-cell, soluble and periplasm fractions, corresponding to the RgpA precursor polypeptide (183 kDa). P. gingivalis W50 and pg1058+ complement strains possessed a distinct band at ~45 kDa, corresponding to the mature catalytic domain (RgpAcat). A series of bands can also be seen in W50 and the pg1058+ complement fractions (~60–80 kDa) which correspond to the MW of the mature post-translationally modified RgpB. The high MW band (~97 kDa) visualised in the pg1058 mutant is likely to be a partially cleaved precursor form of RgpA (Fig 5B).

The Kgp precursor polypeptide consists of the Kgp catalytic domain followed by five adhesin domains (KgpA1, KgpA2, KgpA3, KgpA4 and KgpA5). Similarly, the RgpA precursor polypeptide consists of the RgpA catalytic domain followed by four adhesin domains (RgpAA1, RgpAA2, RgpAA3 and RgpAA4). The precursors are both proteolytically processed to each produce a catalytic domain which is non-covalently associated with the cleaved adhesin domains in a RgpA/Kgp complex [57]. The anti-rKgpA1 antiserum has been shown to recognise KgpA1 as well as RgpA/Kgp complex proteins with MWs which correspond to the RgpAA1, RgpAA3, KgpA3 and HagAA3 adhesins [58]. Immunoblot with anti-rKgpA1 antiserum showed high MW bands (~170–190 kDa) in all fractions of the pg1058 mutant, which corresponded to the MW of Kgp, RgpA and HagA full-length and partially processed precursors. W50 and the pg1058+ complement possessed bands of ~41 kDa and ~43 kDa in all fractions except for the periplasm, which based on identification of bands in Glew et al. [34] correspond to fully processed KgpA1 and RgpAA1. Proteins with MWs corresponding to processed and modified RgpAA4 (45–55 kDa) and RgpA and Kgp polypeptide precursors (97–181 kDa) were also detected in W50 and the pg1058+ complement (Fig 5C).

Using antiserum raised against the CTD sequence of RgpB (anti-rRgpB-CTD422) showed that the pg1058 mutant possessed abundant RgpB CTD in all fractions. Due to sequence conservation within the CTD of the CTD-family proteins [15], the anti-rRgpB-CTD422 antiserum may cross-react with the CTDs of other T9SS substrates. Protein bands were detected that ranged between ~51 and 181 kDa, that may include RgpB, RgpA and Kgp precursors (78, 183 and 186 kDa respectively). In contrast, P. gingivalis W50 and the pg1058+ complement possessed minimal CTD-family proteins with which the anti-rRgpB-CTD422 antiserum reacted. Overall this suggests that in the pg1058 mutant the CTD is not proteolytically cleaved from RgpB and other T9SS substrates as they are in the W50 wild-type. The RgpB CTD was detected in both the culture fluid (CF) and vesicle-free cleared culture fluid (CCF) with equivalent signal intensity suggesting the RgpB precursor was soluble and not vesicle-associated (Fig 5D).

Enzyme-linked immunosorbent assay (ELISA) using formalin-killed whole-cells (FKWC) and anti-rKgpcat antisera showed that at antisera dilutions of 1/10,000-1/80,000 there was no significant difference between the pg1058 and kgp mutant strains in the level of Kgpcat detected (p<0.05), which was significantly lower than that detected for W50 at each dilution (p<0.05). This demonstrates the absence of Kgp on the surface of the pg1058 mutant (Fig 6).

Fig 6. Absence of surface-associated Kgp in the pg1058 mutant determined by whole-cell ELISA analysis.

FKWC (109 per well) prepared from P. gingivalis W50 (positive control), pg1058 mutant and kgp mutant (negative control) were probed with two-fold dilutions of anti-rKgpcat antisera (1/5,000–1/80,000) followed by goat anti-rabbit HRP-conjugated IgG (1/3,000) and developed with ABTS chromogenic substrate. The chromogenic reaction was stopped and detected at 405 nm. Controls included no primary antibody control (No 1°Ab), no secondary antibody control (No 2°Ab) and no cell control (No Bacteria). Mean ± SEM (standard error of the mean), N = 3 for each strain.

Combined these data confirm that T9SS substrates including RgpA, RgpB and Kgp are aberrantly translocated in the pg1058 mutant compared to W50, being found predominantly in the periplasm as precursor forms rather than OM-associated mature forms.

Presence of A-LPS in the pg1058 mutant

T9SS substrates are post-translationally modified with A-LPS, which is proposed to anchor the proteins to the cell surface [21, 33, 34]. Given that the T9SS substrates were aberrantly accumulating in the pg1058 mutant periplasm, analyses were performed to determine if A-LPS was present in the mutant (Fig 7). Immunoblot of subcellular fractions from the W50, pg1058 mutant and pg1058+ complement strains using MAb 1B5, an APS-specific antibody, recognised material in all fractions except for the periplasm. High MW material (~34–105 kDa) was present in W50 and the pg1058+ complement strains, whilst the pg1058 mutant possessed lower MW material of mostly ~7–78 kDa. The material was more strongly associated with the membrane and osmotically-shocked cell fractions of all strains, and was also likely to be vesicle-associated due to its reduced signal in the CCF. The comparatively low MW of the cell-associated material in the pg1058 mutant relative to W50 suggests that in this mutant the A-LPS is not conjugated to the T9SS substrate proteins (Fig 7A).

Fig 7. Presence of A-LPS in the pg1058 mutant.

A. P. gingivalis W50, pg1058 mutant and pg1058+ complement strain cultures were fractionated, separated via SDS-PAGE and immunoblotted on nitrocellulose membranes (as per Fig 5). Immunoblots were probed with MAb 1B5 (1/10,000 dilution) followed by horse anti-mouse IgG-conjugated HRP secondary antibody (1/3,000 dilution). B. Whole-cell ELISA of P. gingivalis W50 and pg1058 mutant FKWC (109 per well) probed with two-fold dilutions of MAb 1B5 from 1/100–1/1,600 followed by horse anti-mouse HRP-conjugated IgG secondary antibody (1/3,000) and developed with ABTS chromogenic substrate. The chromogenic reaction was stopped and detected at 405 nm. Controls included no primary antibody control (No 1°Ab), no secondary antibody control (No 2°Ab) and no cell control (No Bacteria). Mean ± SEM, N = 3 for each strain. C. Immunogold TEM micrographs representative of the P. gingivalis W50 (N = 19) and pg1058 mutant (N = 29). Probing with MAb 1B5 (1/10,000 dilution) was followed by detection with anti-mouse IgG conjugated to 18 nm colloidal gold particles (1/40 dilution). D. The immunogold particle distribution. Distance between IM and centre of the gold particle measured in nm, distances less than 0 nm correspond to a cytoplasmic and IM localisation, 0–20 nm corresponds to the periplasmic space, 21–120 corresponds to the OM and extracellular environment. Mean ± SEM.

The presence of A-LPS on the surface of the pg1058 mutant was indicated by whole-cell ELISA which showed there was no significant difference in the level of surface-associated A-LPS detected between W50 and the pg1058 mutant at the antisera dilutions tested (p>0.05), which were both significantly greater than that detected for the E. coli negative control strain which does not produce A-LPS (p<0.05) (Fig 7B). This was confirmed by immunogold TEM using MAb 1B5 whereby the distribution of gold particles relative to the IM suggested that the APS component of A-LPS recognised by MAb 1B5 is associated with the cell surface and extracellular environment in both W50 and the pg1058 mutant (Fig 7C and 7D).

Combined, these results indicated that while T9SS substrates were not secreted, processed or surface-associated in the pg1058 mutant as they were in W50, A-LPS was produced, secreted and surface-associated indicating that PG1058 is not essential for A-LPS secretion.

PG1058 is not essential for maintenance of OM integrity

Proteins with OmpA_C-like domains have been proposed to stabilise the cellular architecture by providing a connection between the OM and the peptidoglycan layer [59]. It was therefore considered prudent to explore the possibility that the T9SS defect observed in the pg1058 mutant could stem from perturbed incorporation of the T9SS apparatus into the OM due to aberrant cellular architecture (beyond the loss of EDSL). Gram stain of the wild type and pg1058 cells showed that both were coccoid, with no evidence of elongation or distorted morphology in the pg1058 mutant (data not shown). TEM showed that the pg1058 mutant possessed normal OM architecture when compared to W50 with no gross difference in the appearance of the OM, peptidoglycan layer or division septa and no evidence of OM detachment or blebbing at the cell poles (S3A Fig). Antimicrobial sensitivity disc diffusion assays using chloramphenicol, metronidazole, tetracycline, SDS and Triton X-100 also indicated no notable difference in susceptibility between mutant and W50 (S3B Fig), based on current standards which specify a difference in zones of inhibition of >4 mm between susceptible and resistant strains [60]. These data indicate that the gross cell architecture is not compromised and the OM permeability barrier is intact in the pg1058 mutant.

PG1058 is an OM-associated periplasmic protein

Immunoblot of subcellular fractions using anti-rPG1058 antiserum indicated PG1058 to be ~75 kDa protein associated principally with the whole-cells of W50 and the pg1058+ complement (Fig 8A). This agrees with the predicted MW of 73.0 kDa. PG1058 was also detected in the CF and vesicle fractions, suggesting that PG1058 detected in the CF was due to the presence of low abundance PG1058 in the vesicles. Isolation and differential detergent solubilisation of the total membrane fraction showed that PG1058 associated predominantly with the total membrane fraction and the sarkosyl-soluble membrane fraction, indicating that PG1058 is predominantly in the IM or the inner leaflet of the OM (Fig 8A). In addition, PG1058 was found associated with the osmotically-shocked membrane fractions with minimal PG1058 visualised within the soluble periplasmic fraction, which is consistent with PG1058 being membrane-associated.

Fig 8. PG1058 is an OM-associated periplasmic protein.

A. P. gingivalis W50, pg1058 mutant and pg1058+ complement strain cultures were fractionated, separated via SDS-PAGE and immunoblotted on nitrocellulose membranes. The immunoblots have material derived from vesicles (5 x 109 cells); whole-cells (WC; 2 x 108 cells), culture fluid (CF; from culture containing 2 x 109 cells) and vesicle-free cleared culture fluid (CCF; from culture containing 2 x 109 cells); WC (2 x 108 cells), soluble (5 x 109 cells), total membrane (Membrane; 1.6 x 1010 cells), sarkosyl-insoluble membrane (SI; 1.6 x 1010 cells) and sarkosyl-soluble membrane (SS; 1.6 x 1010 cells) fractions; WC (5 x 108 cells), periplasm (5 x 108 cells) and osmotically-shocked cell (OSC; 5 x 108 cells) fractions. Immunoblots were probed with anti-rPG1058 (1/10,000 dilution) and horse anti-mouse IgG-conjugated HRP secondary antibody (1/3,000 dilution). B. Whole-cell ELISA. P. gingivalis W50, pg1058 mutant, pg1058+ complement FKWC or lysed P. gingivalis W50 FKWC as a positive control (2 x 109 cells per well) were probed with anti-rPG1058 antiserum (1/100, 1/200, 1/400, 1/800 and 1/1600 dilutions) followed by horse anti-mouse HRP-conjugated IgG secondary antibody (1/3,000) and developed with ABTS chromogenic substrate. The chromogenic reaction was suspended and detected at 405 nm. Other controls included no primary antibody control (No 1°Ab), no secondary antibody control (No 2°Ab) and no cell control (No Bacteria). Mean ± SEM, N = 3 for each strain except where only one replicate (N = 1) of the positive control (Positive) was assessed. C. P. gingivalis W50 total membrane was separated via sucrose density gradient centrifugation then fractions were separated by SDS-PAGE and immunoblotted on nitrocellulose membrane. Fraction numbers are indicated above the lanes and P refers to the pellet (unequal loading). Immunoblots were probed with anti-rPG1058 (1/10,000 dilution) or anti-Omp41 (1/10,000 dilution) followed by horse anti-mouse IgG-conjugated HRP secondary antibody (1/3,000 dilution).

To investigate whether PG1058 was surface-exposed in P. gingivalis, a whole-cell ELISA was performed using anti-rPG1058 antiserum. There was little difference in the signal detected between the W50 and pg1058 mutant whole-cells (p>0.05) whereas the signal was enhanced when lysed W50 cells were used to coat the wells (Fig 8B). This suggests that P. gingivalis W50 does not possess surface-exposed PG1058 epitopes, indicating instead that PG1058 has an intraperiplasm location.

Isopycnic sucrose density gradient centrifugation was employed to separate the P. gingivalis IM and OM from the total membrane fraction. Proteomic analyses of fractions 16–25 showed that the membrane proteins were predominantly found in fractions 21–25. IM proteins were most abundant in fractions 21–23 while the OM proteins were clearly enriched in fractions 24 and 25, indicating effective separation of the IM and OM (S4 Fig). Immunoblot using anti-rPG1058 showed that PG1058 was broadly dispersed, being detectable in fractions 10–25 as well as the pellet, but was most abundant in fraction 25 (Fig 8C). Immunoblot analysis of the integral outer membrane Omp41 showed the high MW form of Omp41 in fractions 15–25 with a low MW form found in fractions 21–25 as well as the pellet (Fig 8C). The most intense Omp41-specific signal was in fraction 25, suggesting co-localisation of PG1058 and Omp41 in the same cell fraction. This again suggests that PG1058 is associated with the OM. Together the data indicate that PG1058 is present in the periplasm of P. gingivalis and is anchored to the inner leaflet of the OM.


The T9SS of the Bacteroidetes and Chlorobi phyla is the most recently identified of the bacterial protein secretion systems. The T9SS is involved in the OM secretion of proteins, which are subsequently surface-associated in some species through glycosyl modification [15, 17, 20, 28]. A T9SS defect can result from disruptions to any of the many genes coding for components of the linked secretion, A-LPS synthesis and modification processes. Prior to the study presented here, more than twenty P. gingivalis proteins have been shown to affect protein secretion and glycosylation, particularly of the gingipains. The bioinformatic approach employed herein identified twenty-nine proteins as putative T9SS components, sixteen of which were shown experimentally to affect T9SS substrates and three which were previously identified by a bioinformatic investigation alone [27]. Thus ten new candidate T9SS components have been identified, most with putative broad functional assignments or no predicted function (Table 1).

In this study we chose to test the hypothesis that PG1058 is a T9SS component. PG1058 was initially identified as a protein (PG4) with sequence homology to OmpA_C of E. coli, during a screen for potential vaccine antigen targets produced by P. gingivalis W50 [39]. In the P. gingivalis W83 genome sequence deposited at NCBI, pg1058 was annotated as coding for an OmpA-family protein [61]. OmpA is not a known component of a protein secretion system so the annotation may be one reason PG1058 was overlooked in earlier searches for T9SS components.

This study demonstrated that pg1058 is the third gene in an operon that includes pg1056 and pg1057, which suggested that the proteins coded by the operon may be functionally associated. Homology searching suggests that pg1056 codes for a putative 6-pyruvoyl tetrahydrobiopterin synthase (QueD) whilst pg1057 codes for a putative 7-carboxy-7-deazaguanine synthase (QueE). These enzymes are involved in the synthesis of queuosine (nucleoside Q), a modified guanosine derivative found in some tRNAs [62]. Several genes involved in the queuosine biosynthesis pathway form a queCDEF operon in a number of species including Bacillus subtilis and Acinetobacter spp. [63]. There is no similarity between pg1058 and queC, queF or any other genes involved in queuosine biosynthesis. In P. gingivalis W83, queC and queF homologues are likely to be pg1310 and pg1347 respectively. Although the pg1056-pg1058 gene arrangement is conserved within some species of the Bacteroidetes, it is not ubiquitous. The association of pg1056 and pg1057 with pg1058 is likely coincidental and due to a recombination event, frequently observed in P. gingivalis [64].

Cleavage of the CTD, glycosyl modification and surface-association of the T9SS substrates is a feature common to the T9SS of several Bacteroidetes spp., with A-LPS suggested to be the anchor in P. gingivalis [20, 21, 33, 34, 65]. In this study, inactivation of pg1058 resulted in a loss of cell-associated proteinase activity and immunoblotting indicated that Kgp, RgpA and RgpB precursor proteins accumulated in the periplasm of the pg1058 mutant. This was confirmed by proteomic analyses which showed these and other T9SS substrates were accumulating in the mutant’s periplasm, which coincided with the depletion of T9SS substrates in the membrane fraction. Combined this provided strong evidence that PG1058 is a component of the T9SS in P. gingivalis essential for the efficient secretion of the T9SS substrates.

Immunoblotting of P. gingivalis subcellular fractions with an APS-specific antibody (MAb 1B5) suggested that A-LPS was present, however the lower MW indicated it was not conjugated to the T9SS substrates. It was subsequently confirmed that A-LPS was present on the surface of the pg1058 mutant, with abundance similar to that of W50. Together this suggested that the A-LPS involved in the modification and surface-association of the T9SS substrates in P. gingivalis can be transported independently of the T9SS.

A non-capsule electron-dense surface layer (EDSL) is present on the surface of P. gingivalis cells [33]. Mutants with defective secretion of CTD-family proteins (porT, porV, porU) as well as mutants lacking A-LPS (porR, wbaP) have no EDSL [22, 23, 33, 34, 66, 67] suggesting involvement of both T9SS substrates and A-LPS in EDSL formation. A triple gingipain mutant was shown to have considerably reduced EDSL supporting the presence of gingipains in this layer but also suggesting the involvement of other T9SS substrates and/or A-LPS [23]. The involvement of T9SS substrate proteins in the electron density was confirmed in this study with the pg1058 mutant that lacks surface-associated T9SS substrates (Fig 6) shown to be devoid of EDSL (Fig 3D). The presence of surface-associated A-LPS on the pg1058 mutant indicates that A-LPS alone is not sufficient to generate a detectable level of electron density (Fig 7B–7D). Therefore the absence of EDSL in A-LPS mutants is likely due to CTD-family proteins (T9SS substrates) not being surface-associated.

It was considered that the T9SS defect may have resulted from perturbation of the OM and peptidoglycan architecture of the cell since PG1058 possessed sequence homology to TolB and Pal, proteins involved in maintenance of OM integrity. However, antimicrobial sensitivity of the pg1058 mutant was similar to W50, which indicated an intact OM permeability barrier (S3B Fig). Furthermore, TEM indicated that the morphology and architecture of W50 and the mutant were similar (S3A Fig). In contrast, tol and pal depletion mutants of Gram-negative Caulobacter crescentus and Erwinia chrysanthemi exhibited membrane blebbing and abnormal division septa [68, 69]. Furthermore, P. gingivalis ATCC 33277 pgm6/pgm7 deletion mutants lacking OmpA homologues had irregular, wavy OM architecture and increased proteinase activity [70]. Thus it was concluded that PG1058 does not play a crucial role in maintenance of OM integrity.

PG1058 was predicted to be a lipoprotein in P. gingivalis thus localised to the IM or OM through N-terminal acylation. In this study, analysis of osmotically-shocked P. gingivalis cells demonstrated the presence of PG1058 in the residual osmotically-shocked membrane fraction but not the soluble periplasm fraction, confirming that PG1058 is anchored to the cell structure (Fig 8A). The vesicles and the sarkosyl-soluble fraction of the P. gingivalis total membrane were shown to harbour the majority of PG1058 present in the cell (Fig 8A). It has been proposed that the sarkosyl-soluble fraction consists of the phospholipids of the IM as well as the inner leaflet of the OM [71, 72]. The presence of PG1058 in vesicles as well as the sarkosyl-soluble membrane fraction suggests that PG1058 localises to the inner leaflet of the OM, since vesicles prepared from P. gingivalis lack IM proteins [73]. The OM localisation of PG1058 is further supported by the co-localisation of integral outer membrane Omp41 with PG1058 in membrane fractions separated by isopycnic sucrose density gradient centrifugation, enriched for OMPs (Fig 8C). A whole-cell ELISA indicated that PG1058 is not surface exposed in P. gingivalis supporting a periplasmic localisation (Fig 8B). Structural prediction of PG1058 also suggested that the C-terminal domain is similar to peptidoglycan binding proteins in other bacteria. This prediction would be consistent with PG1058 bridging between the OM and peptidoglycan from N to C terminus.

In all known two-step secretion systems utilising Sec for IM transit, there is a mechanism by which the substrates transit the periplasm. This may be through interaction with a chaperone (type VIII and chaperone/usher pathway) or through interaction with a periplasm spanning complex (type II) [7476]. Therefore it is expected that the T9SS substrates will interact with T9SS components within the periplasm. Of the sixteen proteins shown experimentally to influence T9SS secretion, fourteen have been specifically localised; four to the IM (PorL, PorM, PorX and PorY), eight to the OM (LptO, PorK, PorN, PorP, PorQ, PorT, Sov and PG0534) and two as OM-associated extracellular proteins (PorU and PG1604) [27, 31, 33, 34, 38, 73, 77, 78]. PG1058 is the first of the T9SS components to have been localised to the periplasm via anchoring to the inner leaflet of the OM.

The most N-terminal domain of PG1058 contains three TPR repeats. TPR repeats form two antiparallel α–helices and are commonly found as tandem arrays of 3–16 copies, however individual or several blocks of TPR motifs can be dispersed among the protein sequence [40, 41]. A right-handed superhelical structure can form from multiple TPR copies, which has a concave groove for interaction with a protein ligand. The TPR motif is conserved based on residues of structural importance where bulky aromatic residues such as tyrosine and phenylalanine juxtapose small residues such as glycine and alanine, rather than specific functional residues. The “hypervariable” residues dictate the specific ligand interaction [41, 79]. Within the hypervariable region of the PG1058 homologues, lysine residues are particularly well conserved, as are aspartic acid and glutamic acid, suggestive of a possibly charged surface for ligand binding (Fig 2).

The WD40 repeats of β–propellers are canonically 40–60 residues and end with a conserved tryptophan-aspartate (WD) dipeptide [42]. Each blade of the propeller is formed by a single WD40 repeat folded into a four-stranded antiparallel β-sheet [42, 43]. The β-propeller domain also exhibits residue conservation based on structural constraints on the topology [33]. The residues which are well conserved between blades would likely be of structural relevance, with the small glycine and aspartic acid residues conserved in the PG1058 homologues possibly aiding the packing of blades (Fig 2). As with the TPR domain, hypervariable residues of PG1058 would be those most likely to be relevant for specific function. TPR domains are involved in protein-protein interactions and can form large homomultimers or act as scaffolds in multiprotein complexes [41, 47, 79]. Similarly β–propeller proteins are structurally rigid and can form scaffolds for larger protein complexes [43, 80]. It is therefore conceivable that the TPR and β-propeller domains of PG1058 could serve as a structural scaffold for assembly of T9SS components.

The LSX2RAX2VX3L motif is conserved in the family of OmpA_C-like peptidoglycan binding domains [44, 46] and is also present in PG1058 and its homologues (Fig 2). The N-terminal domains of proteins with OmpA_C-like domains have variable topologies. Integral OMPs such as OmpA have OM β–barrel domains [81], lipoproteins such as Pal have short, lipidated N-terminal sequences for anchorage to the OM [82] and MotB has a trans-membrane helix for anchorage to the IM [46]. Others such as RmpM of N. meningitidis, have undetermined N-terminal domain structures [45]. Structural modelling of P. gingivalis PG1058 against RmpM suggests it has residues in the region where RmpM has an extended alpha helix, followed by an additional helix not present in the H. pylori MotB and H. influenzae Pal proteins [45] (Fig 1). PG1058 would likely also have structural features in this region not evident in the other proteins. Overall, the structure of PG1058 is predicted to be far more complex than that of other OmpA-family proteins, thus PG1058 and its homologues may represent a new group of peptidoglycan binding proteins.

The CRD fold was originally identified as a non-catalytic β-barrel or β-sandwich fold in the duck hormone processing regulatory enzyme carboxypeptidase D [83], although the function of this domain has not yet been experimentally shown. In the PG1058 homologues, the CRD domain demonstrates the most sequence variability, in both composition and length.

The intricacy of substrate secretion and modification, and the potential number of T9SS components indicates that the T9SS may have a complexity that is yet to be fully appreciated. Further investigation of the newly identified T9SS component PG1058 is warranted in order to elucidate its precise function.

Using comparative genome sequence analysis we identified ten novel candidate components of the T9SS in P. gingivalis and other Bacteroidetes. One of these, PG1058, was shown in this study to be essential for function of the T9SS in P. gingivalis. PG1058 is a periplasmic protein anchored to the OM, and appears to be a multidomain protein of novel structure.

Materials and Methods

Bioinformatic prediction of T9SS components

A reference protein data set was produced for identification of T9SS candidate proteins. The dataset comprised the entire proteome of selected Bacteroidetes spp. containing predicted T9SS substrates, labelled “CTD-positive” and species from Bacteroidetes and other phyla that did not have predicted T9SS substrates, labelled “CTD-negative” [73]. P. gingivalis W83 was selected as the reference proteome for comparison. Bacteroidetes CTD-positive species were Capnocytophaga ochracea DSM 7271, Chitinophaga pinensis DSM 2588, C. hutchinsonii ATCC 33406, Dyadobacter fermentans DSM 18053, Flavobacteriaceae Bacterium 3519 10, F. johnsoniae UW101, Flavobacterium psychrophilum JIP02, Gramella forsetii KT0803, P. distasonis ATCC 8503, Pedobacter heparinus DSM 2366, P. gingivalis W83, R. marinus DSM 4252, Robiginitalea biformata HTCC2501, Salinibacter ruber DSM 1385 and Spirosoma linguale DSM 74, downloaded from NCBI, plus Prevotella intermedia 17 and T. forsythia ATCC 43037 obtained from the ORALGEN database (, no longer supported). Bacteroidetes CTD-negative species were Bacteroides fragilis NCTC 9343, B. thetaiotaomicron VPI-5482 and Bacteroides vulgatus ATCC 8482. An additional five non-Bacteroidetes spp. were also used as CTD-negative species. These were Clostridium tetani E88, E. coli K102, Neisseria gonorrhoeae FA 1090, N. meningitidis MC58 and Pseudomonas aeruginosa PA7, downloaded from NCBI. The differential analysis used BLASTp [84] where each protein sequence in P. gingivalis was aligned with each protein sequence in the other Bacteroidetes spp. Default parameters were used during the BLASTp search. The BLASTp score for the best hit for each alignment was obtained and put into a scoring matrix. Batch BLAST was used in order to automate and accelerate the alignments. Three parameters were then used as filters to select protein sequences that were conserved amongst the CTD-positive and absent in the CTD-negative species; mean positives scores (MPS), mean negatives scores (MNS) and ratio of MPS over MNS (Difference Ratio). The parameters were optimised by analysing the parameter values for sequences of proteins shown experimentally to be T9SS components. These were PorK, PorL, PorM, PorN, PorP, PorQ, PorT, PorU, PorV, PorW, PorX, PorY and Sov. The optimised cut-off values were MPS ≥ 80, MNS ≤ 80 and Difference Ratio ≥ 2. The final filter applied was that each P. gingivalis protein must have a BLASTp score higher than the ANS in at least ten CTD-positive organisms. The list of candidates was then validated by BLASTp searching against the entire NCBI non-redundant protein database using the default parameters. Each candidate was only accepted if the top 100 protein matches were all from the Bacteroidetes phylum.

PG1058 homologues in Bacteroidetes spp. were identified by BLASTp searches using the P. gingivalis W83 PG1058 as the query. The list of candidate homologues were refined by retaining only those homologues with the lowest expect value for a particular strain, exhibiting more than 60% sequence coverage and containing all four PG1058 domains (TPR, β-propeller, CRD or OmpA_C-like). Sequences that had regions relative to PG1058 of more than 70 additional residues were removed (47 sequences) and examined separately. Multiple sequence alignments were produced using the COBALT (constraint-based alignment tool for multiple protein sequences) [85] and CLUSTAL W [51] tools in BioEdit [86]. A sequence logo indicating sequence conservation was generated from the alignment using WebLogo 3 [52, 53].

Bacterial growth conditions

P. gingivalis strains were grown anaerobically (80% N2, 10% H2, and 10% CO2; MG500 anaerobic workstation; Don Whitley Scientific Ltd.) at 37°C in Heart Infusion (HI, Oxide) broth (3.7% w/v) supplemented with 5 μg/mL haemin and 0.5 mg/mL cysteine hydrochloride and maintained on horse blood agar (HBA; 3.7% w/v Blood agar base No. 2, Oxoid; 10% (v/v) lysed horse blood). Bacterial strains used in this study are listed in S1 Table.

P. gingivalis cell numbers were determined by comparing culture OD to a growth curve previously prepared by this laboratory where OD was related to cell numbers. The OD650 0.6 is equivalent to approximately 2.5 x 109 cells/mL for P. gingivalis, which is within the exponential phase of growth.

Inactivation and complementation of pg1058

P. gingivalis W50 genomic DNA (gDNA) was isolated using the DNeasy® Blood and Tissue kit (Qiagen). Ligated plasmids were used to transform E. coli α-Select cells (Bioline) and sequences verified. All oligonucleotide primers used in this study are listed in S2 Table. An internal region of pg1058 (1935 nt) was amplified from P. gingivalis W50 gDNA using primers PG1058_fwd1 and PG1058_rev1 and ligated into pGEM®-T Easy (Promega). A 731 nt pg1058 fragment was excised from this plasmid by BsaBI digestion and replaced by ermF obtained by RsaI digestion of pVA2198 [87]. This suicide plasmid was linearised by PstI digestion and used to transform P. gingivalis W50 by electroporation [88]. Transformants were selected on HBA plates supplemented with erythromycin (10 μg/mL). Correct homologous recombination into the transformant genome was determined by PCR. A verified transformant with the internal region of pg1058 deleted and replaced by ermF was designated the pg1058 mutant strain ECR370.

The pg1058 mutant was complemented in trans with a copy of the pg1058 ORF. The cepA gene and promoter was PCR amplified from plasmid pEC474 [89] using primers cepAf and cepAr, ligated into the pGEM®-T Easy plasmid, generating pCS19. Primers PG0176ntigrNcoIFWD and PG0176LdrREsREV were used to amplify the DNA upstream of the P. gingivalis W50 mfa1 gene with the addition of a 5’ NcoI RE site and a 3’ multiple cloning site. This amplicon was digested with NcoI and SacII, ligated to NcoI/SacII-digested pCS19, generating pMfa1_up. A second amplicon containing the 5’ region of mfa1 was produced with the addition of a 5’ SpeI and 3’ NdeI RE site using primers PG0176GnSpeIFWD and PG0176GnNdeIREV. This amplicon was SpeI/NdeI-digested, ligated to SpeI/Nde-digested pMfa1_up, generating pMfa1cepA in which cepA is flanked 5’ by DNA homologous to the nucleotides upstream of mfa1 and 3’ by the start of the mfa1 ORF. The pg1058 ORF (2,042 nt) was amplified from P. gingivalis W50 gDNA with the addition of a 5’ BamHI and 3’ SacII RE site using PG1058compBamHIFor and PG1058compSacIIRev primers and ligated into pGEM®-T Easy, generating pGEM:pg1058. The pg1058 ORF was excised from pGEM:pg1058 by digestion with BamHI and SacII and ligated to BamHI/SacII-digested pMfa1cepA, generating p1058cepA with pg1058 in the same orientation as mfa1. This recombination cassette was excised by digestion with DraIII and SacI and used to transform the pg1058 mutant (ECR370). A transformant was selected on HBA supplemented with ampicillin (5 μg/mL), verified and designated the pg1058+ complement strain ECR756.

P. gingivalis cell harvesting and fraction preparation

P. gingivalis cells were harvested from cultures grown to exponential phase by centrifugation at 8,000 g, 4°C for 25 min. During preparation of subcellular fractions, cultures were supplemented with protease inhibitors (1 mM tosyl-L-lysyl-chloromethane hydrochloride, TLCK, Sigma-Aldrich; 1 mM EDTA; 0.1% v/v PIC, Sigma-Aldrich) and additional protease inhibitors (1 mM TLCK, 1 mM EDTA, 0.1% v/v) were included in wash buffers, added to the samples during fractionation and to the final fractions. Harvested cells were washed in TC150 buffer (150 mM NaCl, 50 mM Tris-HCl, pH 8.0) unless indicated otherwise.

Whole-cell extracts designated here as whole-cell fractions (WC), culture fluid (CF) and vesicle-free cleared culture fluid (CCF) fractions were obtained as previously described [33] except for isolation of the CCF by ultracentrifugation of CF at 338,000 g, 4°C for 40 min. The vesicle pellets (V) were washed in phosphate buffered saline (PBS, pH 7.4) and retained.

Periplasm fractions (PP) were obtained by osmotic-shock of washed cells as previously described [33] with aliquots of the cell suspensions collected as representative of whole-cell fractions (WC) prior to centrifugation, and pellets retained and designated osmotically-shocked cells (OSC).

Membrane fractions were prepared via differential detergent solubilisation as previously published [16] with minor changes. Samples of washed cells were retained as whole-cell fractions (WC). Cells were lysed using a French® Pressure Cell Press with a 40,000 psi French® Press Cell (SLM Instruments, USA) set to 1,500 psi instead of sonication, and all ultracentrifugation steps were performed at 176,000 g, 4°C for 30 min. Supernatants containing soluble cytoplasmic and periplasmic proteins were collected and designated soluble fractions (SOL) and pellets containing the membrane fraction were designated total membrane fractions (Membrane). Separation of the sarkosyl-soluble supernatant (SS) and sarkosyl-insoluble pellets (SI) was performed using a 2% w/v sarkosyl solution instead of 10% w/v, and TC150 buffer was used for all steps instead of PBS.

CF, CCF and PP fractions were precipitated with 12% v/v trichloroacetic acid (TCA), washed with acetone and suspended to 1/10 of the starting volume in 25 mM Tris-HCl (pH 7.5).

The protein concentration of each sample was determined relative to the number of cells used to generate the sample. All protein samples were compared based on equivalent cell numbers.

The P. gingivalis total membrane was isolated and underwent isopycnic sucrose density gradient centrifugation as previously published [90] with minor changes. Phenylmethylsulfonyl fluoride, leupeptin and RNase were not used in sample preparation; non-lysed cells were removed from cell lysate by centrifugation at 8,000 g, 4°C for 25 min; the total membrane was suspended with the aid of sonication on ice for a total of 5 min (pulses of 30 s on, 30 s off) using a CPX750 Ultrasonic processor (20% amplitude) fitted with a 6.5 mm tapered microtip probe (Cole Parmer Instrument Company). The sucrose gradient consisted of 1.7 mL of 2.02 M sucrose, 5.9 mL of 1.44 M sucrose, 4.2mL of 0.77 M sucrose prepared in 10 mM HEPES-NaOH (pH 7.4) in an ultracentrifuge tube (344060, Ultra-Clear™, Beckman Coulter). The relative volume of each sucrose solution was consistent with the published protocol. The gradients were ultracentrifuged at 100,000 g, 4°C for 20 h using a SW40Ti rotor (Beckman Coulter™ Inc.). Fractions (0.5 mL) were collected by careful pipetting from the top of the ultracentrifuge tube.

Immunoblot analysis

P. gingivalis subcellular fractions were suspended in 1X NuPAGE® LDS Sample Buffer (Invitrogen™) supplemented with 50–100 mM DTT. Samples were resolved by SDS-PAGE and transferred onto nitrocellulose membrane using NuPAGE® reagents and precast gels (Invitrogen™). The membrane was blocked with 5% non-fat skim milk in PBST0.1 (0.1% v/v Tween-20 in PBS) and probed with primary antibody followed by a goat anti-rabbit or horse anti-mouse horseradish peroxidase (HRP)-conjugated IgG secondary antibody (Cell Signaling Technology Inc.). The signal was detected by SuperSignal West Pico chemiluminescent substrate (Quantum Scientific) or Immobilon® Western chemiluminescent HRP substrate (Merck Millipore,) and visualised with a LAS-3000 imaging instrument (FUJI). In some cases, the bound antibody was removed using stripping solution (2% w/v SDS; 63 mM Tris-HCl pH 6.8; 0.8% v/v 2-mercapotoethanol, Sigma-Aldrich) and the membranes were then re-probed with different primary and secondary antibodies for detection of different proteins.

Mouse monoclonal antibody 1B5 (MAb 1B5) was a gift from Professor M.A. Curtis, Royal London School of Medicine and Dentistry, London, United Kingdom [19]. Mouse monoclonal antibody anti-Omp41 was a gift from CSL™ (Parkville, Victoria, Australia). Anti-rRgpB-CTD422 (previously designated anti-rRgpB-CTD(422)) [34] and anti-rKgpA1 [58] were mouse polyclonal antisera raised against purified E. coli His-tagged recombinant proteins. Anti-rRgpAcat mouse polyclonal antisera was raised against purified E. coli His-tagged recombinant protein, which was subsequently preadsorbed with P. gingivalis YH522 rgpA-, rgpB- mutant cell lysate [15]. Purified recombinant Kgp enzyme [91] was used to raise anti-rKgpcat rabbit polyclonal antisera. A purified E. coli His-tagged protein rPG1058 produced using an expression plasmid, which was a gift from CSL Ltd., Australia, was used to raise the mouse polyclonal antisera anti-rPG1058.

Haemagglutination activity assay

Haemagglutination activity assay was performed using washed P. gingivalis cells as described previously [33] except for the use of sheep erythorcytes instead of horse.

Proteinase activity assays

P. gingivalis cells were washed in TC150 buffer (150 mM NaCl, 50 mM Tris-HCl, 5 mM CaCl2, pH 8.0,) supplemented with cysteine hydrochloride (10 mM), suspended in an equivalent culture volume of the same solution and designated whole-cell fractions. Culture supernatants were ultracentrifuged at 103,900 g, 4°C for 40 min and designated supernatant fractions. Fractions were analysed for Arg- and Lys-specific proteinase activities as previously described [91] using chromogenic substrates N-α-benzoyl-L-Arg-p-nitroanilide (BApNA) and Kgp substrate was N-Tosylglycyl-L-prolyl-L-lysine4-nitroanilide acetate salt (LpNA). The Arg- and Lys-specific assay mixtures contained either whole-cell fractions (3.8 x 107 and 5 x 107 cells respectively) or supernatant fractions (45 μL and 60 μL respectively), cysteine hydrochloride (10 mM), 2 mM BApNA or LpNA and 5% (v/v) dimethyl sulfoxide made up to 200 μL in TC150 buffer. The release of pNA was monitored using a microtitre plate reader (Wallac VICTOR™ 3 Multilabel Counter, PerkinElmer™ Pty. Ltd.) by the change in OD at 405 nm over time.

Cryo-electron microscopy (Cryo-EM)

P. gingivalis cells were washed in pre-filtered TM20 buffer (20 mM Tris-HCl, pH 7.4, 20 mM NaCl, 10 mM MgCl2) and suspended in the same buffer to 1/5 of the original culture volume. Cell suspensions (6 μL) underwent cryo-fixation and TEM imaging under cryogenic conditions as previously described [33].

Whole-cell enzyme linked immunosorbant assay (ELISA)

P. gingivalis and E. coli α-Select cells were harvested from exponential phase cultures and formalin-killed whole-cells (FKWC) were prepared as previously described [33]. Whole-cell ELISAs were performed using FKWC as previously described [33], except where 2 x 109 FKWC were used to coat the wells, the blocking solution contained 5% (w/v) skim-milk in PBST0.1 and antibodies prepared in blocking solution were incubated for 1 h. Colour development was stopped via addition of stop solution (final concentration 1 mg/mL NaF) and the optical density was measured at 405 nm (0.1 s) using a microtitre plate reader (Wallac VICTOR™ 3 Multilabel Counter).

Immunogold transmission electron microscopy

P. gingivalis cells were washed and suspended in PBS to 1/80 culture volume and incubated on ice. Cell suspensions (2 μL) underwent cryo-fixation and immunogold labelling as previously described [92] using MAb 1B5 (1/10,000 dilution) and anti-mouse secondary antibody conjugated to 18 nm colloidal gold particles (diluted 1:40). Micrographs were taken with a Phillips CM120 Biotwin transmission electron microscope (Koninklijke Philips N.V.) at 120 kV using a Gatan Multiscan 600CW digital camera (Gatan Inc.). Gold particle distribution was enumerated using Image J [93] by measuring the distance between the outer edge of the IM (0 nm) and the centre of the gold particle, rounded to the nearest 5 nm, and comparing the number of gold particles within a given 10 nm region. Gold particles present in the cytoplasm were given negative distances.

Liquid chromatography tandem mass spectrometry (LC-MS/MS)

For analysis of the entire periplasm fraction (7.5 x 109 cells) or total membrane fraction (4 x 108 cells) samples from a SimplyBlue™ SafeStain stained SDS-PAGE gel, the whole lane was cut into several segments each containing multiple protein bands. Each segment was treated as a separate sample. Proteins in isopycnic sucrose density gradient centrifugation fractions were precipitated using 15% v/v TCA, washed with acetone and suspended in 5.3 M urea in NH4HCO3. All samples underwent reduction with dithiothreitol, alkylation with iodoacetamide, trypsin digestion and acidification with trifluoroacetic acid as previously described [73]. Peptides underwent LC-MS/MS analysis with the same search parameters as previously published [73]. The subcellular localisation of P. gingivalis proteins used for analysis of subcellular fractions in this study is summarised in S3 Table, based on data generated during preparation of Veith et al. [73].

PG1058 structure prediction

Structure modelling was done using Phyre2 [94] with program default parameters. Additional modelling of the β-propeller domain was performed using the InterPro database [95].


Data were analysed using IBM SPSS Statistics Version 22. Data were analysed using a one-way analysis of variance (ANOVA) with a Fisher’s Least Significant Difference (LSD) post hoc test for multiple comparisons with statistical significance at p<0.05. Data were assumed to be normally distributed with homogeneous variance.

Supporting Information

S1 Fig. Alignments and secondary structure predictions of PG1058 domains predicted by Phyre2.

A. The TPR domain aligned to 412wA, the myosin chaperone unc-45 from Caenorhabditis elegans B. The β–propeller domain aligned to c2w8bB, E. coli TolB. Note the lack of homology in places, which results in fewer blades predicted in PG1058 than in the template molecule. C. The CRD domain aligned to cmn8A, Drosophila melanogaster carboxypeptidase d isoform 1b2 short. D. The OmpA_C domain aligned to c1r1m1, the OmpA-like domain from RmpM of Neisseria meningitidis.


S2 Fig. Inactivation and complementation of pg1058 did not affect the expression of pg1056 and pg1057 in the operon.

A. RT-PCR using a reverse oligonucleotide primer specific for pg1058 and forward oligonucleotide primers specific for pg1056, pg1057 or pg1058 transcripts with no template (NTC), W50 gDNA, reverse transcribed W50 RNA and W50 RNA that was not reverse transcribed (No RT) indicated that pg1058 is the third gene in a three gene operon. B. Non-endpoint RT-PCR was performed using oligonucleotide primer pairs specific to pg1056, pg1057 and pg1058 with no template (NTC), W50 gDNA, reverse transcribed W50 RNA, reverse transcribed pg1058 mutant RNA and reverse transcribed pg1058+ complement RNA indicated that transcription of pg1056 and pg1057 was not affected in the pg1058 mutant. See S1 Experimental Procedures.


S3 Fig. Normal OM architecture and integrity in the pg1058 mutant.

A. TEM analysis of the P. gingivalis OM architecture. TEM micrographs (93-180k X magnification) representative of the P. gingivalis W50 and pg1058 mutant indicate the division septum and cell poles of the pg1058 mutant appear normal with no evidence of OM blebbing. Outer membrane (OM), inner membrane (IM) and peptidoglycan (PGN), division septum and cell poles (arrows) are indicated. Scale bars are 100 or 200 nm as indicated. B. Antimicrobial sensitivity disc diffusion assay. Discs impregnated with chloramphenicol (CHL, 10 μg), metronidazole (MTZ, 1 μg), tetracycline (TET, 0.40 μg), SDS (0.25 μg) or Triton X-100 (0.53 μg) were placed on agar plates seeded with W50 or pg1058 mutant cells. The zone of growth inhibition (mm) was measured after 24 h. Mean ± SEM; N = 4; ** indicates p<0.01. See S1 Experimental Procedures.


S4 Fig. Proteomic analyses of isopycnic sucrose density gradient fractionation of the P. gingivalis total membrane.

The combined Mascot score of confirmed non-CTD OM proteins (black bars) and IM proteins (white bars) within each fraction was compared to the total Mascot score for all proteins identified in that fraction as a percentage. N = 1.


S1 Table. Bacterial Strains.

A, ATCC: American Type Culture Collection. B, Strain ECR669 has kgp from the Met codon to the stop codon substituted with cepA [89] that codes a cephalosporinase. This mutant was made by flanking cepA with >300 nt of DNA immediately 5’ and 3’ to kgp and using this to transform P. gingivalis W50. Replacement of kgp occurred after homologous recombination, with transformants selected on HBA supplemented with 5 μg/mL of ampicillin.


S3 Table. P. gingivalis W50 protein localisation used for proteomic analyses.



Dr Simon Crawford, School of BioSciences, The University of Melbourne prepared bacterial cells for transmission electron microscopy and provided JEH with transmission electron microscopy technical training. Rachel Sore from the Statistical Consulting Centre, The University of Melbourne gave advice on statistical analyses of small data sets.

Author Contributions

  1. Conceptualization: JEH CAS PDV CAB SGD ECR.
  2. Formal analysis: JEH.
  3. Funding acquisition: ECR.
  4. Investigation: JEH CAS NANM YYC BP SMC KJC.
  5. Methodology: JEH CAS NANM PDV CAB NS.
  6. Project administration: ECR.
  7. Resources: LZ CM ECR.
  8. Supervision: CAS PDV CAB SGD ECR.
  9. Visualization: JEH CAS.
  10. Writing – original draft: JEH CAS.
  11. Writing – review & editing: JEH CAS PDV CAB ECR.


  1. 1. Wiebe CB, Putnins EE. The periodontal dsease classification system of the American Academy of Periodontology—An update. J Can Dent Assoc. 2000;66: 594–597. pmid:11253351
  2. 2. Tonetti MS, Dyke TE. Periodontitis and atherosclerotic cardiovascular disease: Consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases. J Clin Periodontol. 2013;40: S24–S29. pmid:23627332
  3. 3. Linden GJ, Lyons A, Scannapieco FA. Periodontal systemic associations: Review of the evidence. J Clin Periodontol. 2013;40: S8–S19. pmid:23627336
  4. 4. Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL. Microbial complexes in subgingival plaque. J Clin Periodontol. 1998;25: 134–144. pmid:9495612
  5. 5. Haffajee AD, Cugini MA, Tanner A, Pollack RP, Smith C, Kent RL, et al. Subgingival microbiota in healthy, well-maintained elder and periodontitis subjects. J Clin Periodontol. 1998;25: 346–353. pmid:9650869
  6. 6. Byrne SJ, Dashper SG, Darby IB, Adams GG, Hoffmann B, Reynolds EC. Progression of chronic periodontitis can be predicted by the levels of Porphyromonas gingivalis and Treponema denticola in subgingival plaque. Oral Microbiol Immunol. 2009;24: 469–477. pmid:19832799
  7. 7. Darveau R, Hajishengallis G, Curtis M. Porphyromonas gingivalis as a potential community activist for disease. J Dent Res. 2012;91: 816–820. pmid:22772362
  8. 8. Hajishengallis G, Darveau RP, Curtis MA. The keystone-pathogen hypothesis. Nat Rev Microbiol. 2012;10: 717–725. pmid:22941505
  9. 9. Hajishengallis G, Lamont RJ. Breaking bad: Manipulation of the host response by Porphyromonas gingivalis. Eur J Immunol. 2014;44: 328–338. pmid:24338806
  10. 10. Lamont RJ, Jenkinson HF. Life below the gum line: Pathogenic mechanisms of Porphyromonas gingivalis. Microbiol Mol Biol Rev. 1998;62: 1244–1263. pmid:9841671
  11. 11. O'Brien-Simpson NM, Paolini RA, Hoffmann B, Slakeski N, Dashper SG, Reynolds EC. Role of RgpA, RgpB, and Kgp proteinases in virulence of Porphyromonas gingivalis W50 in a murine lesion model. Infect Immun. 2001;69: 7527–7534. pmid:11705929
  12. 12. O'Brien-Simpson NM, Pathirana RD, Paolini RA, Chen Y-Y, Veith PD, Tam V, et al. An immune response directed to proteinase and adhesin functional epitopes protects against Porphyromonas gingivalis-induced periodontal bone loss. J Immunol. 2005;175: 3980–3989. pmid:16148146
  13. 13. O'Brien-Simpson NM, Pathirana RD, Walker GD, Reynolds EC. Porphyromonas gingivalis RgpA-Kgp proteinase-adhesin complexes penetrate gingival tissue and induce proinflammatory cytokines or apoptosis in a concentration-dependent manner. Infect Immun. 2009;77: 1246–1261. pmid:19114547
  14. 14. Potempa J, Pike R, Travis J. Titration and mapping of the active site of cysteine proteinases from Porphyromonas gingivalis (gingipains) using peptidyl chloromethanes. Biol Chem. 1997;378: 223–230. pmid:9165075
  15. 15. Seers CA, Slakeski N, Veith PD, Nikolof T, Chen Y- Y, Dashper SG, et al. The RgpB C-terminal domain has a role in attachment of RgpB to the outer membrane and belongs to a novel C-terminal-domain family found in Porphyromonas gingivalis. J Bacteriol 2006;188: 6376–6386. pmid:16923905
  16. 16. Nguyen K- A, Travis J, Potempa J. Does the importance of the C-terminal residues in the maturation of RgpB from Porphyromonas gingivalis reveal a novel mechanism for protein export in a subgroup of Gram-negative bacteria? J Bacteriol 2007;189: 833–843. pmid:17142394
  17. 17. Shoji M, Sato K, Yukitake H, Kondo Y, Narita Y, Kadowaki T, et al. Por secretion system-dependent secretion and glycosylation of Porphyromonas gingivalis hemin-binding protein 35. PLoS One. 2011;6: e21372. pmid:21731719
  18. 18. Sato K, Sakai E, Veith PD, Shoji M, Kikuchi Y, Yukitake H, et al. Identification of a new membrane-associated protein that influences transport/maturation of gingipains and adhesins of Porphyromonas gingivalis. J Biol Chem. 2005;280: 8668–8677. pmid:15634642
  19. 19. Curtis MA, Thickett A, Slaney JM, Rangarajan M, Aduse-Opoku J, Shepherd P, et al. Variable carbohydrate modifications to the catalytic chains of the RgpA and RgpB proteases of Porphyromonas gingivalis W50. Infect Immun. 1999;67: 3816–3823. pmid:10417143
  20. 20. Veith PD, Talbo GH, Slakeski N, Dashper SG, Moore C, Paolini RA, et al. Major outer membrane proteins and proteolytic processing of RgpA and Kgp of Porphyromonas gingivalis W50. Biochem J. 2002;363: 105–115. pmid:11903053
  21. 21. Veith PD, Nor Muhammad NA, Dashper SG, Likić VA, Gorasia DG, Chen D, et al. Protein substrates of a novel secretion system are numerous in the Bacteroidetes phylum and have in common a cleavable C-terminal secretion signal, extensive post-translational modification, and cell-surface attachment. J Proteome Res. 2013;12: 4449–4461. pmid:24007199
  22. 22. Paramonov N, Rangarajan M, Hashim A, Gallagher A, Aduse-Opoku J, Slaney JM, et al. Structural analysis of a novel anionic polysaccharide from Porphyromonas gingivalis strain W50 related to Arg-gingipain glycans. Mol Microbiol. 2005;58: 847–863. pmid:16238632
  23. 23. Gorasia DG, Veith PD, Chen D, Seers CA, Mitchell HA, Chen Y- Y, et al. Porphyromonas gingivalis type IX secretion substrates are cleaved and modified by a sortase-like mechanism. PLoS Path. 2015;11: e1005152. pmid:26340749
  24. 24. Shoji M, Nakayama K. Glycobiology of the oral pathogen Porphyromonas gingivalis and related species. Microb Pathog. 2015: 1–7. pmid:26456570
  25. 25. Saiki K, Konishi K. Identification of a Porphyromonas gingivalis novel protein Sov required for the secretion of gingipains. Microbiol Immunol. 2007;51: 483–491. pmid:17579257
  26. 26. Ishiguro I, Saiki K, Konishi K. PG27 is a novel membrane protein essential for a Porphyromonas gingivalis protease secretion system. FEMS Microbiol Lett. 2009;292: 261–267. pmid:19187201
  27. 27. Sato K, Naito M, Yukitake H, Hirakawa H, Shoji M, McBride MJ, et al. A protein secretion system linked to bacteroidete gliding motility and pathogenesis. Proc Natl Acad Sci U S A. 2010;107: 276–281. pmid:19966289
  28. 28. Sato K, Yukitake H, Narita Y, Shoji M, Naito M, Nakayama K. Identification of Porphyromonas gingivalis proteins secreted by the Por secretion system. FEMS Microbiol Lett. 2013;338: 68–76. pmid:23075153
  29. 29. McBride MJ, Zhu Y. Gliding motility and Por secretion system genes are widespread among members of the phylum Bacteroidetes. J Bacteriol 2013;195: 270–278. pmid:23123910
  30. 30. Stock AM, Robinson VL, Goudreau PN. Two-component signal transduction. Ann Rev Biochem. 2000;69: 183–215. pmid:10966457
  31. 31. Kadowaki T, Yukitake H, Naito M, Sato K, Kikuchi Y, Kondo Y, et al. A two-component system regulates gene expression of the type IX secretion component proteins via an ECF sigma factor. Sci Rep. 2016;6: 23288. pmid:26996145
  32. 32. Gorasia DG, Veith PD, Hanssen EG, Glew MD, Sato K, Yukitake H, et al. Structural Insights into the PorK and PorN Components of the Porphyromonas gingivalis Type IX Secretion System. PLoS Pathog. 2016;12: e1005820. pmid:27509186
  33. 33. Chen YY, Peng B, Yang Q, Glew MD, Veith PD, Cross KJ, et al. The outer membrane protein LptO is essential for the O-deacylation of LPS and the co-ordinated secretion and attachment of A-LPS and CTD proteins in Porphyromonas gingivalis. Mol Microbiol. 2011;79: 1380–1401. pmid:21244528
  34. 34. Glew MD, Veith PD, Peng B, Chen Y- Y, Gorasia DG, Yang Q, et al. PG0026 is the C-terminal signal peptidase of a novel secretion system of Porphyromonas gingivalis. J Biol Chem. 2012;287: 24605–24617. pmid:22593568
  35. 35. Glew MD, Veith PD, Chen D, Seers CA, Chen Y- Y, Reynolds EC. Blue native-PAGE analysis of membrane protein complexes in Porphyromonas gingivalis. J Proteomics. 2014;110: 72–92. pmid:25111759
  36. 36. Saiki K, Konishi K. Porphyromonas gingivalis C‐terminal signal peptidase PG0026 and HagA interact with outer membrane protein PG27/LptO. Mol Oral Microbiol. 2014;29: 32–44. pmid:24289791
  37. 37. Dou Y, Osbourne D, McKenzie R, Fletcher HM. Involvement of extracytoplasmic function sigma factors in virulence regulation in Porphyromonas gingivalis W83. FEMS Microbiol Lett. 2010;312: 24–32. pmid:20807237
  38. 38. Saiki K, Konishi K. Identification of a novel Porphyromonas gingivalis outer membrane protein, PG534, required for the production of active gingipains. FEMS Microbiol Lett. 2010;310: 168–174. pmid:20695897
  39. 39. Ross BC, Czajkowski L, Hocking D, Margetts M, Webb E, Rothel L, et al. Identification of vaccine candidate antigens from a genomic analysis of Porphyromonas gingivalis. Vaccine. 2001;19: 4135–4142. pmid:11457538
  40. 40. Allan RK, Ratajczak T. Versatile TPR domains accommodate different modes of target protein recognition and function. Cell Stress Chaperones. 2011;16: 353–367. pmid:21153002
  41. 41. Das AK, Cohen PW, Barford D. The structure of the tetratricopeptide repeats of protein phosphatase 5: Implications for TPR-mediated protein-protein interactions. EMBO J. 1998;17: 1192–1199. pmid:9482716
  42. 42. Carr S, Penfold CN, Bamford V, James R, Hemmings AM. The structure of TolB, an essential component of the tol-dependent translocation system, and its protein–protein interaction with the translocation domain of colicin E9. Structure. 2000;8: 57–66. pmid:10673426
  43. 43. Chen CK, Chan NL, Wang AH. The many blades of the beta-propeller proteins: Conserved but versatile. Trends Biochem Sci. 2011;36: 553–561. pmid:21924917
  44. 44. De Mot R, Vanderleyden J. The C-terminal sequence conservation between OmpA-related outer membrane proteins and MotB suggests a common function in both Gram-positive and Gram-negative bacteria, possibly in the interaction of these domains with peptidoglycan. Mol Microbiol. 1994;12: 333–334. pmid:8057857
  45. 45. Grizot S, Buchanan SK. Structure of the OmpA-like domain of RmpM from Neisseria meningitidis. Mol Microbiol. 2004;51: 1027–1037. pmid:14763978
  46. 46. Roujeinikova A. Crystal structure of the cell wall anchor domain of MotB, a stator component of the bacterial flagellar motor: Implications for peptidoglycan recognition. Proc Natl Acad Sci U S A. 2008;105: 10348–10353. pmid:18647830
  47. 47. D'Andrea LD, Regan L. TPR proteins: The versatile helix. Trends Biochem Sci. 2003;28: 655–662. pmid:14659697
  48. 48. Gazda L, Pokrzywa W, Hellerschmied D, Löwe T, Forné I, Mueller-Planitz F, et al. The myosin chaperone UNC-45 is organized in tandem modules to support myofilament formation in C. elegans. Cell. 2013;152: 183–195. pmid:23332754
  49. 49. Bonsor DA, Hecht O, Vankemmelbeke M, Sharma A, Krachler AM, Housden NG, et al. Allosteric β‐propeller signalling in TolB and its manipulation by translocating colicins. EMBO J. 2009;28: 2846–2857. pmid:19696740
  50. 50. Tanco S, Arolas JL, Guevara T, Lorenzo J, Avilés FX, Gomis-Rüth FX. Structure–function analysis of the short splicing variant carboxypeptidase encoded by Drosophila melanogaster silver. J Mol Biol. 2010;401: 465–477. pmid:20600119
  51. 51. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, et al. Clustal W and Clustal X version 2.0. Bioinformatics. 2007;23: 2947–2948. pmid:17846036
  52. 52. Crooks GE, Hon G, Chandonia J- M, Brenner SE. WebLogo: A sequence logo generator. Genome Res. 2004;14: 1188–1190. pmid:15173120
  53. 53. Schneider TD, Stephens RM. Sequence logos: A new way to display consensus sequences. Nucleic Acids Res. 1990;18: 6097–6100. pmid:2172928
  54. 54. Smalley JW, Thomas MF, Birss AJ, Withnall R, Silver J. A combination of both arginine- and lysine-specific gingipain activity of Porphyromonas gingivalis is necessary for the generation of the micro-oxo bishaem-containing pigment from haemoglobin. Biochem J. 2004;379: 833–840. pmid:14741050
  55. 55. Smalley J, BIRSS A, Withnall R, Silver J. Interactions of Porphyromonas gingivalis with oxyhaemoglobin and deoxyhaemoglobin. Biochem J. 2002;362: 239–245. pmid:11829761
  56. 56. Smalley JW, Silver J, Marsh PJ, Birss AJ. The periodontopathogen Porphyromonas gingivalis binds iron protoporphyrin IX in the mu-oxo dimeric form: an oxidative buffer and possible pathogenic mechanism. Biochem J. 1998;331: 681–685. pmid:9560292
  57. 57. O'Brien-Simpson NM, Veith PD, Dashper SG, Reynolds EC. Porphyromonas gingivalis gingipains: the molecular teeth of a microbial vampire. Curr Protein Pept Sci. 2003;4: 409–426. pmid:14683427
  58. 58. Frazer LT, O’Brien-Simpson NM, Slakeski N, Walsh KA, Veith PD, Chen CG, et al. Vaccination with recombinant adhesins from the RgpA–Kgp proteinase–adhesin complex protects against Porphyromonas gingivalis infection. Vaccine. 2006;24: 6542–6554. pmid:16839648
  59. 59. Park JS, Lee WC, Yeo KJ, Ryu K-S, Kumarasiri M, Hesek D, et al. Mechanism of anchoring of OmpA protein to the cell wall peptidoglycan of the gram-negative bacterial outer membrane. FASEB J. 2012;26: 219–228. pmid:21965596
  60. 60. Dudley MN, Ambrose PG, Bhavnani SM, Craig WA, Ferraro MJ, Jones RN, et al. Background and rationale for revised clinical and laboratory standards institute interpretive criteria (breakpoints) for Enterobacteriaceae and Pseudomonas aeruginosa: I. Cephalosporins and Aztreonam. Clin Infect Dis. 2013;56: 1301–1309. pmid:23334813
  61. 61. Nelson KE, Fleischmann RD, DeBoy RT, Paulsen IT, Fouts DE, Eisen JA, et al. Complete genome sequence of the oral pathogenic bacterium Porphyromonas gingivalis strain W83. J Bacteriol 2003;185: 5591–5601. pmid:12949112
  62. 62. Slany R, Kersten H. Genes, enzymes and coenzymes of queuosine biosynthesis in procaryotes. Biochimie. 1994;76: 1178–1182. pmid:7748953
  63. 63. Reader JS, Metzgar D, Schimmel P, de Crécy-Lagard V. Identification of four genes necessary for biosynthesis of the modified nucleoside queuosine. J Biol Chem. 2004;279: 6280–6285. pmid:14660578
  64. 64. Naito M, Hirakawa H, Yamashita A, Ohara N, Shoji M, Yukitake H, et al. Determination of the genome sequence of Porphyromonas gingivalis strain ATCC 33277 and genomic comparison with strain W83 revealed extensive genome rearrangements in P. gingivalis. DNA Research. 2008;15: 215–225. pmid:18524787
  65. 65. Rangarajan M, Aduse-Opoku J, Paramonov N, Hashim A, Bostanci N, Fraser OP, et al. Identification of a second lipopolysaccharide in Porphyromonas gingivalis W50. J Bacteriol 2008;190: 2920–2932. pmid:18263730
  66. 66. Shoji M, Ratnayake DB, Shi Y, Kadowaki T, Yamamoto K, Yoshimura F, et al. Construction and characterization of a nonpigmented mutant of Porphyromonas gingivalis: Cell surface polysaccharide as an anchorage for gingipains. Microbiology. 2002;148: 1183–1191. pmid:11932462
  67. 67. Shoji M, Sato K, Yukitake H, Naito M, Nakayama K. Involvement of the Wbp pathway in the biosynthesis of Porphyromonas gingivalis lipopolysaccharide with anionic polysaccharide. Sci Rep. 2014;4: pmid:24852504
  68. 68. Dubuisson J- F, Vianney A, Hugouvieux-Cotte-Pattat N, Lazzaroni JC. Tol-Pal proteins are critical cell envelope components of Erwinia chrysanthemi affecting cell morphology and virulence. Microbiology. 2005;151: 3337–3347. pmid:16207916
  69. 69. Yeh Y- C, Comolli LR, Downing KH, Shapiro L, McAdams HH. The Caulobacter Tol-Pal complex is essential for outer membrane integrity and the positioning of a polar localization factor. J Bacteriol 2010;192: 4847–4858. pmid:20693330
  70. 70. Iwami J, Murakami Y, Nagano K, Nakamura H, Yoshimura F. Further evidence that major outer membrane proteins homologous to OmpA in Porphyromonas gingivalis stabilize bacterial cells. Oral Microbiol Immunol. 2007;22: 356–360. pmid:17803635
  71. 71. Deslauriers M, Lamonde L, Mouton C. SDS‐PAGE analysis of protein and lipopolysaccharide of extracellular vesicules and sarkosyl‐insoluble membranes from Bacteroides gingivalis. Oral Microbiol Immunol. 1990;5: 1–7. pmid:1708119
  72. 72. Filip C, Fletcher G, Wulff JL, Earhart CF. Solubilization of the cytoplasmic membrane of Escherichia coli by the ionic detergent sodium-lauryl sarcosinate. J Bacteriol 1973;115: 717–722. pmid:4580564
  73. 73. Veith PD, Chen Y-Y, Gorasia DG, Chen D, Glew MD, O’Brien-Simpson NM, et al. Porphyromonas gingivalis outer membrane vesicles exclusively contain outer membrane and periplasmic proteins and carry a cargo enriched with virulence factors. J Proteome Res. 2014;13: 2420–2432. pmid:24620993
  74. 74. Evans ML, Chapman MR. Curli biogenesis: Order out of disorder. Biochim Biophys Acta. 2014;1843: 1551–1558. pmid:24080089
  75. 75. Geibel S, Waksman G. The molecular dissection of the chaperone–usher pathway. Biochim Biophys Acta. 2014;1843: 1559–1567. pmid:24140205
  76. 76. Korotkov KV, Sandkvist M, Hol WGJ. The type II secretion system: Biogenesis, molecular architecture and mechanism. Nat Rev Microbiol. 2012: 336. pmid:22466878
  77. 77. Nguyen K- A, Żylicz J, Szczesny P, Sroka A, Hunter N, Potempa J. Verification of a topology model of PorT as an integral outer-membrane protein in Porphyromonas gingivalis. Microbiology. 2009;155: 328–337. pmid:19202082
  78. 78. Saiki K. The role of Sov protein in the secretion of gingipain protease virulence factors of Porphyromonas gingivalis. FEMS Microbiol Lett. 2010;302: 166. pmid:20002184
  79. 79. Zeytuni N, Zarivach R. Structural and functional discussion of the tetra-trico-peptide repeat, a protein interaction module. Structure. 2012;20: 397–405. pmid:22404999
  80. 80. Kopec KO, Lupas AN. β-propeller blades as ancestral peptides in protein evolution. PLoS One. 2013;8: e77074. pmid:24143202
  81. 81. Pautsch A, Schulz GE. High-resolution structure of the OmpA membrane domain. J Mol Biol. 2000;298: 273–282. pmid:10764596
  82. 82. Parsons LM, Lin F, Orban J. Peptidoglycan recognition by Pal, an outer membrane lipoprotein. Biochemistry (Mosc). 2006;45: 2122–2128. pmid:16475801
  83. 83. Gomis‐Rüth FX, Companys V, Qian Y, Fricker LD, Vendrell J, Avilés FX, et al. Crystal structure of avian carboxypeptidase D domain II: A prototype for the regulatory metallocarboxypeptidase subfamily. EMBO J. 1999;18: 5817–5826. pmid:10545093
  84. 84. Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, et al. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res. 1997;25: 3389–3402. pmid:9254694
  85. 85. Papadopoulos JS, Agarwala R. COBALT: Constraint-based alignment tool for multiple protein sequences. Bioinformatics. 2007;23: 1073–1079. pmid:17332019
  86. 86. Hall TA, editor BioEdit: A user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symposium Series; 1999.
  87. 87. Fletcher HM, Schenkein HA, Morgan RM, Bailey KA, Berry CR, Macrina FL. Virulence of a Porphyromonas gingivalis W83 mutant defective in the prtH gene. Infect Immun. 1995;63: 1521–1528. pmid:7890419
  88. 88. Slakeski N, Seers CA, Ng K, Moore C, Cleal SM, Veith PD, et al. C-terminal domain residues important for ecretion and attachment of RgpB in Porphyromonas gingivalis. J Bacteriol 2011;193: 132–142. pmid:20971915
  89. 89. Rogers MB, Bennett TK, Payne CM, Smith CJ. Insertional activation of cepA leads to high-level beta-lactamase expression in Bacteroides fragilis clinical isolates. J Bacteriol 1994;176: 4376–4384. pmid:7517394
  90. 90. Murakami Y, Imai M, Nakamura H, Yoshimura F. Separation of the outer membrane and identification of major outer membrane proteins from Porphyromonas gingivalis. Eur J Oral Sci. 2002;110: 157–162. pmid:12013560
  91. 91. Huq NL, Seers CA, Toh ECY, Dashper SG, Slakeski N, Zhang L, et al. Propeptide-mediated inhibition of cognate gingipain proteinases. PLoS One. 2013;8: e65447. pmid:23762374
  92. 92. Hu M, Crawford Simon A, Henstridge Darren C, Ng Ivan HW, Boey Esther JH, Xu Y, et al. p32 protein levels are integral to mitochondrial and endoplasmic reticulum morphology, cell metabolism and survival. Biochem J. 2013;453: 381–391. pmid:23692256
  93. 93. Abramoff MD, Magalhaes PJ, Ram SJ. Image processing with ImageJ. Biophotonics Int. 2004;11: 36–43.
  94. 94. Kelley LA, Sternberg MJE. Protein structure prediction on the web: a case study using the Phyre server. Nature Protocols. 2009;4: 363–371. pmid:19247286
  95. 95. Mitchell A, Chang H-Y, Daugherty L, Fraser M, Hunter S, Lopez R, et al. The InterPro protein families database: The classification resource after 15 years. Nucleic Acids Res. 2015;43: D213–D221. pmid:25428371